van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167–76.
Toyoda K, Yoshimura S, Nakai M, Koga M, Sasahara Y, Sonoda K, et al. Twenty-year change in severity and outcome of ischemic and hemorrhagic strokes. JAMA Neurol. 2021;79(1):61–9.
Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke J Cereb Circ. 2001;32(4):891–7.
Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster GM. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.
Article CAS PubMed Google Scholar
Delcourt C, Huang Y, Arima H, Chalmers J, Davis SM, Heeley EL, Wang J, Parsons MW, Liu G, Anderson CS, Chalmers J. Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology. 2012;79(4):314–9.
Sheth KN. Spontaneous intracerebral hemorrhage. N Engl J Med. 2022;387(17):1589–96.
Article CAS PubMed Google Scholar
Dowlatshahi D, Demchuk AM, Flaherty ML, Ali M, Lyden PL, Smith EE. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76(14):1238–44.
Article CAS PubMed PubMed Central Google Scholar
Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022;53(7):e282-361.
Article CAS PubMed Google Scholar
Woo D, Comeau ME, Venema SU, Anderson CD, Flaherty M, Testai F, et al. Risk factors associated with mortality and neurologic disability after intracerebral hemorrhage in a racially and ethnically diverse cohort. JAMA Netw Open. 2022;5(3): e221103.
Article PubMed PubMed Central Google Scholar
Mrochen A, Sprügel MI, Gerner ST, Sembill JA, Lang S, Lücking H, et al. Thrombocytopenia and clinical outcomes in intracerebral hemorrhage: a retrospective multicenter cohort study. Stroke. 2021;52(2):611–9.
Article CAS PubMed Google Scholar
Roh D, Boehme A, Young C, Roth W, Gutierrez J, Flaherty M, et al. Hematoma expansion is more frequent in deep than lobar intracerebral hemorrhage. Neurology. 2020;95(24):e3386–93.
Article CAS PubMed PubMed Central Google Scholar
Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost. 2005;3(12):2607–11.
Article CAS PubMed Google Scholar
Bolliger D, Görlinger K, Tanaka KA, Warner DS. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology. 2010;113(5):1205–19.
Segal JB, Dzik WH. Transfusion medicine/hemostasis clinical trials network. paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45(9):1413–25.
Sprigg N, Flaherty K, Appleton JP, Salman RA, Bereczki D, Beridze M, Christensen H, Ciccone A, Collins R, Czlonkowska A, Dineen RA. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. The Lancet. 2018;391(10135):2107–15.
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. New Engl J Med. 2008;358(20):2127–37.
Article CAS PubMed Google Scholar
Baharoglu MI, Cordonnier C, Al-Shahi Salman R, de Gans K, Koopman MM, Brand A, Majoie CB, Beenen LF, Marquering HA, Vermeulen M, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet Lond Engl. 2016;387:2605–13.
Baharoglu MI, Al-Shahi Salman R, Cordonnier C, Koopman MM, Manson L, Susen S, Marquering HA, Beenen LF, Majoie CB, Roos YB. PATCH trial: explanatory analyses. Blood. 2020;135:1406–9.
Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, Broderick JP. Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage. Stroke. 2008;39:850–6.
Article CAS PubMed Google Scholar
Magid-Bernstein J, Beaman CB, Carvalho-Poyraz F, Boehme A, Hod EA, Francis RO, Elkind MSV, Agarwal S, Park S, Claassen J, et al. Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage. Blood. 2021;137:2699–703.
Article CAS PubMed Google Scholar
Cotton BA, Faz G, Hatch QM, Radwan ZA, Podbielski J, Wade C, Kozar RA, Holcomb JB. Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma Acute Care Surg. 2011;71(2):407–17.
Holcomb J, Minei K, Scerbo M, Radwan Z, Wade C, Kozar R, Gill B, Albarado R, McNutt M, Khan S, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256:476–86.
Vigneshwar NG, Moore EE, Moore HB, Cotton BA, Holcomb JB, Cohen MJ, Sauaia A. Precision medicine: clinical tolerance to hyperfibrinolysis differs by shock and injury severity. Ann Surg. 2022;275:e605–7.
Johansson PI, Stensballe J, Vindeløv N, Perner A, Espersen K. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis. 2010;21:168.
Laursen TH, Meyer MAS, Meyer ASP, Gaarder T, Naess PA, Stensballe J, Ostrowski SR, Johansson PI. Thrombelastography early amplitudes in bleeding and coagulopathic trauma patients: Results from a multicenter study. J Trauma Acute Care Surg. 2018;84:334–41.
Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, Ghasabyan A, Wohlauer MV, Barnett CC, Bensard DD, Biffl WL, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2016;263:1051–9.
Baksaas-Aasen K, Gall LS, Stensballe J, Juffermans NP, Curry N, Maegele M, Brooks A, Rourke C, Gillespie S, Murphy J, Maroni R. Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial. Intensive Care Med. 2021;47:49–59.
Article CAS PubMed Google Scholar
Jb G. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management*. Anesthesiology. 2006;104:1081–93.
Tjerkstra MA, Wolfs AE, Verbaan D, Vandertop WP, Horn J, Müller MCA, Juffermans NP. A systematic review of viscoelastic testing in patients with subarachnoid hemorrhage. World Neurosurg. 2023;175:102-112.e5.
Kvint S, Schuster J, Kumar MA. Neurosurgical applications of viscoelastic hemostatic assays. Neurosurg Focus. 2017;43:E9.
Anderson TN, Schreiber MA, Rowell SE. Viscoelastic testing in traumatic brain injury: key research insights. Transfus Med Rev. 2021;35:108–12.
Meretoja A, Strbian D, Putaala J, Curtze S, Haapaniemi E, Mustanoja S, Sairanen T, Satopää J, Silvennoinen H, Niemelä M, et al. SMASH-U A proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012;43:2592–7.
Comments (0)